Symbols

IRON

Disc Medicine·NASDAQ

--(--)

IRON Profile

Disc Medicine,Inc.

A clinical stage precision medicine company that developing innovative treatments for genetically-defined age-related macular degeneration

Industry

Biological Technology

Established Date

06/25/2020

Listing Date

08/12/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

155

Fiscal Year Ends

12-31

Website

www.discmedicine.com

Security Type

Common stock

Office address

321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472

Business

Introduction

Disc Medicine, Inc., was incorporated as a Delaware corporation on June 25, 2020. The company is a clinical-stage biopharmaceutical company focused on developing novel therapies for serious blood diseases. Its R&D pipeline targets basic biological pathways in erythropoiesis and function. The main drug candidate bitopertin is being developed for the treatment of erythropoietic porphyria, and other drug candidates target anemia and related diseases.